Clinical Research Directory
Browse clinical research sites, groups, and studies.
Tumor Microenvironment
Sponsor: University Hospital Heidelberg
Summary
Cancer immunotherapy has the great potential to achieve long-term survival in patients with a solid malignancy. However, the beneficial effect of cancer immunotherapy is seen in only a minority of patients. Mounting evidence suggests that immunosuppressive features in the tumor microenvironment prevent an effective antitumor defense. The aim of the investigators is to comprehensively analyze the cytokine profile and the tumor immune infiltrate in the tumor microenvironment and to investigate its prognostic significance in patients with radically resected lung adenocarcinoma.
Official title: Tumor Microenvironment in Lung Adenocarcinoma
Key Details
Gender
All
Age Range
18 Years - 90 Years
Study Type
OBSERVATIONAL
Enrollment
300
Start Date
2016-02
Completion Date
2026-12
Last Updated
2024-05-08
Healthy Volunteers
No